NasdaqGS - Nasdaq Real Time Price USD

Anavex Life Sciences Corp. (AVXL)

Compare
9.28 +0.82 (+9.69%)
As of 2:01:20 PM EST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Expense
51,193.00
55,731.00
50,986.00
41,948.00
30,938.34
Operating Income
-51,193.00
-55,731.00
-50,986.00
-41,948.00
-30,938.34
Net Non Operating Interest Income Expense
7,519.00
5,555.00
947.00
26.00
179.97
Other Income Expense
2,206.00
2,678.00
2,419.00
4,281.00
4,500.57
Pretax Income
-41,468.00
-47,498.00
-47,620.00
-37,641.00
-26,257.81
Tax Provision
60.00
7.00
358.00
268.00
22.66
Net Income Common Stockholders
-41,528.00
-47,505.00
-47,978.00
-37,909.00
-26,280.47
Diluted NI Available to Com Stockholders
-41,528.00
-47,505.00
-47,978.00
-37,909.00
-26,280.47
Basic EPS
-0.51
-0.60
-0.62
-0.54
-0.45
Diluted EPS
-0.51
-0.60
-0.62
-0.54
-0.45
Basic Average Shares
82,766.07
79,787.60
76,909.99
69,802.96
58,194.89
Diluted Average Shares
82,766.07
79,787.60
76,909.99
69,802.96
58,194.89
Total Operating Income as Reported
-51,193.00
-55,756.00
-50,986.00
-42,002.00
--
Total Expenses
51,193.00
55,731.00
50,986.00
41,948.00
30,938.34
Net Income from Continuing & Discontinued Operation
-41,528.00
-47,505.00
-47,978.00
-37,909.00
-26,280.47
Normalized Income
-41,437.94
-47,473.40
-47,263.84
-37,714.82
-26,372.11
Interest Income
7,519.00
6,519.00
947.00
26.00
179.97
Interest Expense
--
964.00
--
--
--
Net Interest Income
7,519.00
5,555.00
947.00
26.00
179.97
EBIT
-41,468.00
-46,534.00
-47,620.00
-37,641.00
-30,938.34
EBITDA
-41,468.00
-46,534.00
-47,620.00
-37,641.00
-30,938.34
Net Income from Continuing Operation Net Minority Interest
-41,528.00
-47,505.00
-47,978.00
-37,909.00
-26,280.47
Total Unusual Items Excluding Goodwill
-114.00
-40.00
-904.00
-266.00
125.54
Total Unusual Items
-114.00
-40.00
-904.00
-266.00
125.54
Normalized EBITDA
-41,354.00
-46,494.00
-46,716.00
-37,375.00
-31,063.88
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-23.94
-8.40
-189.84
-71.82
33.90
9/30/2020 - 8/2/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ANVS Annovis Bio, Inc.
5.11
-3.74%
 
SAVA Cassava Sciences, Inc.
2.7018
-1.75%
 
AXSM Axsome Therapeutics, Inc.
90.66
+0.62%
 
CGTX Cognition Therapeutics, Inc.
0.4644
-2.85%
 
GALT Galectin Therapeutics Inc.
2.2505
+6.64%
 
ALT Altimmune, Inc.
9.10
+0.78%
 
SLS SELLAS Life Sciences Group, Inc.
0.9423
+8.07%
 
CKPT Checkpoint Therapeutics, Inc.
3.3678
-8.25%
 
IOVA Iovance Biotherapeutics, Inc.
7.91
+1.02%
 
RVPH Reviva Pharmaceuticals Holdings, Inc.
2.4900
-4.60%